Researchers determined the use of pharmacological lactate dehydrogenase (LDH) inhibitors to reduce aggressive behavior of breast cancer cells. The effect of LDH inhibitors was investigated in both estrogen receptor (ER)+ and ER‑ breast cancer cell lines and in normal breast epithelial cells.
[Molecular Medicine Reports]